Calendar Johnson & Johnson

Equities

JNJ

US4781601046

Market Closed - Nyse 04:00:02 2024-03-18 pm EDT 5-day change 1st Jan Change
156.8 USD -0.90% Intraday chart for Johnson & Johnson -2.77% +0.01%

Chart calendar Johnson & Johnson

92d12c25ba58da50bb3f210.FqW2_YS1JBcdsxSunUQ-dVfPE7_TLKgiRfcnrHvqbbQ.ZuabufP2T216-WLp2DZSWBKGXPCfbfFMAJ8V5B26PP1vx87P8txsLirQRQ~090a4526f70aa8871af053e056833d4a

Upcoming events on Johnson & Johnson

2024-04-16 06:45 am Q1 2024 Earnings Release
2024-04-16 08:30 am Q1 2024 Earnings Call
2024-04-25 10:00 am Annual General Meeting
2024-07-15 Q2 2024 Earnings Release (Projected)
2024-10-14 Q3 2024 Earnings Release (Projected)
2025-01-27 Q4 2024 Earnings Release (Projected)
2025-04-21 Q1 2025 Earnings Release (Projected)

Past events on Johnson & Johnson

2024-03-13 10:45 am Barclays Global Healthcare Conference
2024-03-12 01:00 pm Leerink Partners Global Biopharma Conference
2024-03-05 02:15 pm Raymond James Institutional Investors Conference
2024-03-04 11:10 am TD Cowen Health Care Conference
2024-02-15 Ex-dividend day
2024-01-24 ASCO Genitourinary Cancers Symposium - Abstract #676
2024-01-24 ASCO Genitourinary Cancers Symposium - Abstract #701
2024-01-24 ASCO Genitourinary Cancers Symposium - Abstract #699
2024-01-24 ASCO Genitourinary Cancers Symposium - Abstract #202
2024-01-24 ASCO Genitourinary Cancers Symposium - Abstract #647
2024-01-24 ASCO Genitourinary Cancers Symposium - Abstract #105
2024-01-24 ASCO Genitourinary Cancers Symposium - Abstract #64
2024-01-24 ASCO Genitourinary Cancers Symposium - Abstract #52
2024-01-24 ASCO Genitourinary Cancers Symposium - Abstract #TPS236
2024-01-24 ASCO Genitourinary Cancers Symposium - Abstract #53D
2024-01-24 ASCO Genitourinary Cancers Symposium - Abstract #316
2024-01-24 ASCO Genitourinary Cancers Symposium - Abstract #294
2024-01-24 ASCO Genitourinary Cancers Symposium - Abstract #223
2024-01-24 ASCO Genitourinary Cancers Symposium - Abstract #65
2024-01-24 ASCO Genitourinary Cancers Symposium - Abstract #58

Past dividends on Johnson & Johnson

2024-02-15 Quarterly 1.19 USD
2023-11-19 Quarterly 1.19 USD
2023-08-24 Quarterly 1.19 USD
2023-05-21 Quarterly 1.19 USD
2023-02-16 Quarterly 1.13 USD
2022-11-20 Quarterly 1.13 USD
2022-08-21 Quarterly 1.13 USD
2022-05-22 Quarterly 1.13 USD
2022-02-17 Quarterly 1.06 USD
2021-11-21 Quarterly 1.06 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
82 059
82 193
-0.16%
82 584
81 721
1.06%
93 775
94 304
-0.56%
94 943
95 017
-0.08%
85 159
84 764
0.47%

88 282

EBITDA
Million USD
Released
Forecast
Spread
27 979
28 680
-2.45%
27 145
27 951
-2.88%
36 634
33 066
10.79%
32 630
32 564
0.2%
30 414
31 998
-4.95%

31 871

EBIT
Million USD
Released
Forecast
Spread
25 593
25 615
-0.09%
24 574
24 992
-1.67%
29 244
30 088
-2.8%
29 965
29 608
1.21%
27 460
27 881
-1.51%

29 119

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
17 328
19 476
-11.03%
16 497
19 030
-13.31%
22 776
24 759
-8.01%
21 725
25 756
-15.65%
15 062
20 454
-26.36%

24 753

Net income
Million USD
Released
Forecast
Spread
15 119
16 943
-10.76%
14 714
15 924
-7.6%
20 878
22 542
-7.38%
17 941
20 668
-13.19%
35 153
17 242
103.88%

20 940

EPS
USD
Released
Forecast
Spread
5,63
6,47
-13.03%
5,51
6,10
-9.72%
7,81
8,42
-7.29%
6,73
7,95
-15.29%
13,7
6,61
107.66%

8,90

Announcement Date22/01/2026/01/2125/01/2224/01/2323/01/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
24 804
25 289
-1.92%
23 426
23 618
-0.81%
24 020
23 825
0.82%
23 791
23 433
1.53%
23 706
23 901
-0.82%
24 746
23 599
4.86%
25 530
24 668
3.49%
21 351
21 049
1.43%
21 395
21 017
1.8%

21 407


22 378


22 200


22 373


21 965

EBITDA
Million USD
Released
Forecast
Spread
7 939
7 401
7.27%
9 305
8 964
3.8%
9 011
8 659
4.07%
9 299
8 682
7.11%
7 804
7 485
4.26%
8 880
8 484
4.66%
8 912
8 671
2.78%
8 071
7 683
5.04%
6 333
6 788
-6.7%

7 747


8 115


8 020


7 751




EBIT
Million USD
Released
Forecast
Spread
6 096
6 790
-10.22%
7 536
7 874
-4.29%
7 267
7 763
-6.39%
7 614
7 858
-3.1%
7 093
6 702
5.83%
8 204
7 411
10.7%
8 189
7 753
5.62%
7 374
6 967
5.83%
5 638
6 015
-6.27%

7 184


7 458


7 501


6 959


7 551

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
4 836
5 551
-12.88%
5 862
7 060
-16.97%
5 840
6 856
-14.82%
5 822
6 646
-12.4%
4 201
6 020
-30.22%
-737
6 708
-110.99%
6 762
7 242
-6.63%
5 217
7 202
-27.56%
4 826
5 043
-4.3%

6 250


6 677


6 612


6 213




Net income
Million USD
Released
Forecast
Spread
4 736
5 475
-13.5%






4 458
5 921
-24.71%
3 520
4 621
-23.82%
-68,0
5 573
-101.22%
5 144
5 866
-12.3%
26 028


4 049
3 631
11.52%

5 383


5 275


5 354


4 627


5 695

EPS
USD
Released
Forecast
Spread
1,77
1,91
-7.33%
1,93
2,17
-11.06%
1,80
2,19
-17.68%
1,68
2,08
-19.36%
1,33
1,87
-29%
-0,03
2,10
-101.43%
1,96
1,89
3.45%
10,2
2,17
370.51%
1,67
1,77
-5.49%

2,23


2,23


2,25


1,97


2,34

Announcement Date25/01/2219/04/2219/07/2218/10/2224/01/2318/04/2320/07/2317/10/2323/01/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Johnson & Johnson - Nyse
  4. Calendar Johnson & Johnson